Retatrutide is a groundbreaking therapy generating substantial buzz in the obesity treatment field. This remarkable peptide, developed Reta by Eli Lilly, functions as a double GIP and GLP-1 site agonist. Essentially, it mirrors the action of these natural hormones, which control appetite and encourage satiety. Clinical trials have indicated impress